IDNA

iShares Genomics Immunology and …

• Seeking Alpha·13h ago

  Can Forgotten Biotech Break Out?

• Seeking Alpha·2d ago

  Concerns Shift From Obsolescence To Oil

• Seeking Alpha·04/04 00:05

  CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

• Seeking Alpha·03/20 07:05

  Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors

• Seeking Alpha·03/19 05:10

  Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals

• Seeking Alpha·03/08 18:42

  The K-Shaped Consumer Economy: GLP-1s, AI And The Future Of Consumer Spending

• Seeking Alpha·03/06 09:00

  The Trump Administration's Affordability Plan

• Seeking Alpha·02/26 11:56

  Q1 Active Management Pulse: Positioning Broadens Beyond AI Leaders

• NASDAQ·02/24 13:00

  AI Scare Back in the Market: ETFs That Stayed Steady

• Seeking Alpha·01/29 04:50

  The Diversification Role Mid-Cap Stocks Can Play

• Seeking Alpha·01/22 18:04

  Healthcare debate should focus on out-of-pocket costs, not list prices – Novartis CEO

• Seeking Alpha·01/22 16:12

  Moderna’s rally ripples through biotech and health care ETFs

• Seeking Alpha·01/22 11:07

  Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?

• Seeking Alpha·01/13 11:30

  U.S. Earnings: Broadening Strength

• NASDAQ·01/09 15:00

  Here's Why Biotech ETFs Are Rallying Hard